Thu 13 Aug 2026
All official websites of government entities in the Kingdom of Saudi Arabia end with.gov.sa.
Ensure the website is using the HTTPS protocol.
Registered with the Digital Government Authority under number:
| Study Title | Study Sponsor | Status | Study Drug | Trial Phase | Study Protocol Number | Site |
|---|---|---|---|---|---|---|
| A Phase 2/3 Randomized, Multicenter Study of Osivelotor Administered Orally to Participants with Sickle Cell Disease and an Open-Label Pharmacokinetics Study in Pediatric Participants with Sickle Cell Disease | Global Therapeutics Inc | Ongoing | Osivelotor | 2/3 | C5351004 (GBT021601) | Prince Mohammad Bin Naser Hospital (Jazan), King Abdulaziz Medical City NG (Riyadh) |
| INTERnational STudy Evaluating Lupus Outcomes after Anifrolumab Real-World Use (INTERSTELLAR): Multi-National, Observational, Prospective, Post-Launch, Effectiveness Study Among SLE Patients Receiving Anifrolumab in Routine Clinical Practice | Astrazeneca | Ongoing | Anifrolumab | 4 | TMP-0010230 | Aseer Central Hospital (Abha), International Medical Center (Jeddah), King Khalid University Hospital (Riyadh) |
| Survey assessing prospective patient’s short-term treatment satisfaction and Quality of Life in patients with Hidradenitis Suppurativa initiated on Cosentyx (Secukinumab) in routine clinical practice in Saudi Arabia | Novartis | Ongoing | Secukinumab | 4 | CAIN457MSA | King Fahad Medical City (Riyadh), King Abdulaziz Medical City NG (Jeddah) |
| Comparing the effectiveness of buccal infiltration of different volumes of Articaine for extraction of mandibular posterior teeth- A randomized clinical trial. | Dental Clinic-collage of Dentistry-Qassim Unviersity | Ongoing | ARTICAINE HYDROCHLORIDE, EPINEPHRINE BITARTRATE | 4 | 6074514624 | Dental Clinic-collage of Dentistry-Qassim Unviersity (Al-Qassim) |
| A Randomized, Double-Blinded, Placebo-Controlled, Phase 3, Parallel-Group Design Study Evaluating the Efficacy and Safety of Efgartigimod IV in Adult Participants With Acetylcholine Receptor Binding Antibody Seronegative Generalized Myasthenia Gravis | Argenx BV | Ongoing | Efgartigimod IV | 3 | ARGX-113-2308 | King Faisal Specialist Hospital and Research Center (Riyadh),King Abdulaziz Medical City NG (Riyadh) |
| A Phase 4, Multicenter, Multi-Country, Open-Label, Single-Arm Study to Investigate the Effectiveness and Safety of Tirzepatide Once Weekly in Adult Participants with Type 2 Diabetes during Ramadan (T-RAM) | Boehringer Ingelheim | Ongoing | BI 690517 Empagliflozin | 4 | 1378-0020 | King Fahad Medical City (Riyadh), King Khalid University Hospital (Riyadh), King Faisal Specialist Hospital and Research Center (Riyadh), King Abdulaziz Medical City NG (Riyadh), King Abdulaziz University Hospital (Jeddah) |
| INTERnational STudy Evaluating Lupus Outcomes after Anifrolumab Real-World Use (INTERSTELLAR): Multi-National, Observational, Prospective, Post-Launch, Effectiveness Study Among SLE Patients Receiving Anifrolumab in Routine Clinical Practice | AstraZeneca | Ongoing | Anifrolumab | 4 | TMP-0010230 | Aseer Central Hospital (Abha), International Medical Center (Jeddah) |
| Phase 3b, Open-label, Multicenter, Single-dose Study Investigating Efficacy and Safety of CSL222 (Etranacogene Dezaparvovec) Gene Therapy Administered to Adult Subjects with Severe or Moderately Severe Hemophilia B with Detectable Pretreatment AAV5 Neutralizing Antibodies | CSL Behring LLC | Ongoing | HEMGENIX (etranacogene dezaparvovec) | 3b | CSL222_3005 | King Faisal Specialist Hospital and Research Center (Riyadh) |
| Long-term pain and adherence observational study for Endometriosis treatment | Abbott | Ongoing | Duphaston | 4 | DYDR-522-0318 | Dr.Arab Clinic |
| Real world Assessment of Dyslipidemia patients on Inclisiran effiCacy And toLerability: The RADICAL Study | Novartis | Ongoing | LEQVIO | 4 | CKJX839A1S | Dallah Hospital (Riyadh),International Medical Center (Jeddah), Armed Force Hospital (Tabuk),My Clinic (Jeddah), Mouwasat Hospital (Dammam) |
Last update date: 08/05/2025 at 03:17 PM Saudi Arabia time
No feedback has been submitted for this page yet.
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.